Amaero and Titomic Establish Strategic Supply and Development Partnership Driving Innovation, Securing the Future
HUNTSVILLE, AL – Titomic Limited (ASX: TTT), a global leader in Titomic Kinetic Fusion™, a cold spray additive manufacturing technology, is pleased to announce the signature of a long-term Strategic Supply and Development Agreement for refractory and titanium alloy spherical powders tailored to cold spray additive manufacturing applications with Amaero Ltd. (ASX:3DA, OTC:AMROF) (“Amaero”).
Highlights:
-
-
- Agreement provides Titomic and its customers with consistent, high-quality powders, critical to unlocking the full potential of cold spray additive manufacturing.
- Agreement underscores the importance of building a resilient and scalable U.S. domestic supply chain for defense, space, and aerospace markets.
- Agreement establishes Amaero as the exclusive supplier of spherical refractory and titanium alloy powders (gas atomized or plasma spheroidized) to support Titomic’s advanced cold spray applications. Other powder types remain unrestricted.
- Partnership aligns Amaero’s powder production capabilities with Titomic’s growth in coatings, repair, and near-net-shape part manufacturing.
- Powders qualified in Titomic’s development programs will be the same formulations offered for production, ensuring continuity and reliability.
- Framework includes pathways for flexibility in sourcing where customer requirements, market conditions, or material availability necessitate alternatives.
-
Jim Simpson, Titomic CEO and Managing Director, commented “For Titomic this partnership gives us the confidence that the powders we use for qualification and development will be the same powders that are available for production, backed by domestic capacity to scale. Amaero’s capabilities complement our own technology and position us to better support defense and aerospace customers with reliable, advanced manufacturing solutions.”
Hank J. Holland, Amaero Chairman and CEO, said “Amaero is committed to aligning with partners who are leading the adoption of advanced manufacturing in the United States. Titomic has built a reputation as a pioneer in cold spray and is well positioned to accelerate adoption across defense and aerospace markets. This agreement reflects our shared vision of providing resilient, scalable, and competitive material solutions to customers where supply chain assurance is paramount.”
This announcement has been authorized for release by Titomic’s Board of Directors.
INVESTOR CONTACT
Geoff Hollis
Titomic
Chief Financial Officer
P: +61 438 168 008
E: geoff.hollis@titomic.com
MEDIA CONTACT
Dr. Patti Dare
Titomic
President, USA
P: +1 408 4975
E: patti.dare@titomic.com
Titomic Limited (ASX: TTT) is a leading American manufacturing company specializing in large integrated solutions for industrial- scale metal additive manufacturing, coating, and repairs using its patented kinetic fusion cold spray (Titomic Kinetic Fusion™) technology. Titomic Kinetic Fusion™ cold spray solutions provide OEM production and R&D services to the global Aerospace, Defense, Shipbuilding, Oil & Gas, Mining and Automotive industries. Titomic also offers global sales and support for all its Titomic Kinetic Fusion™ cold spray AM activities from its Huntsville, Alabama Head Office, as well as through local presence in the Australia and Europe. Titomic delivers competitive advantages in metal additive manufacturing at every stage in the product value chain. For more information, please visit www.titomic.com.
ABOUT Amaero Ltd. (The ASX Listed Company)
Amaero Ltd (ASX:3DA, OTC:AMROF) is an ASX-listed company with manufacturing and corporate headquarters in Tennessee, U.S. Amaero is a leading domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing, serving the defense, space, and aviation industries. The company’s expertise spans gas atomization, advanced powder metallurgy, and PM-HIP manufacturing of near-net-shape powder parts with forged-equivalent material properties.
FORWARD LOOKING STATEMENTS
Certain statements made in this release are forward-looking statements and are based on Titomic’s current expectations, estimates and projections. Words such as “anticipates”, “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “guidance” and similar expressions are intended to identify forward-looking statements. Although Titomic believes the forward-looking statements are based on reasonable assumptions, they are subject to certain risks and uncertainties, some of which are beyond Titomic’s control, including those risks or uncertainties inherent in the process of both developing and commercializing technology. As a result, actual results could materially differ from those expressed or forecasted in the forward-looking statements. The forward-looking statements made in this release relate only to events as of the date on which the statements are made. Titomic will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this release except as required by law or by any appropriate regulatory authority.